Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TOP: TYSABRI Observational Program

NCT00493298 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00493298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TOP: TYSABRI Observational Program
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
June 29, 2007
Completion date
November 1, 2023
Enrollment
6,620 (actual)
Sites
419

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing-remitting multiple sclerosis